Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
2021
Africa
Americas
Clear all
Type of publications
NITAG documentation
(77)
Systematic reviews (SYSVAC)
(5)
Topics
Available to download in languages
Regions
Africa
(17)
Americas
(65)
Europe
(76)
South-East Asia
(2)
Western Pacific
(14)
Countries
Argentina
(1)
Bolivia
(2)
Burkina Faso
(1)
Canada
(16)
Chile
(9)
Nigeria
(1)
Senegal
(2)
Uganda
(12)
United States of America
(37)
Diseases
COVID-19
(81)
Meningococcal disease
(1)
Ebola
(1)
Hepatitis B
(1)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(6)
Malaria
(1)
Poliomyelitis
(2)
Rotavirus
(5)
Tetanus
(2)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(3)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2021
(82)
2024
(1)
2023
(20)
2022
(63)
2020
(64)
2019
(8)
2018
(4)
2017
(1)
2016
(10)
2015
(8)
2014
(6)
2013
(4)
2012
(1)
2011
(7)
2010
(1)
2009
(3)
2008
(1)
2007
(3)
2006
(3)
2005
(1)
1997
(1)
1993
(1)
1991
(1)
82 results found
2021
∙
ACIP
Updates on Thrombosis with Thrombocytopenia Syndrome (TTS)
2021
∙
ACIP
Updates to the benefit/risk assessment for Janssen COVID-19 vaccines
2021
∙
CAVEI
CAVEI RECOMMENDATION ON COVID-19 VACCINATION IN CHILDREN FROM 6 YEARS OLD - 7 September 2021
2021
Enhancing COVID-19 Vaccine Acceptance in Canada
2021
∙
CAVEI
Recommendations of immunization strategies against the occurrence of events supposedly attributable to vaccination and immunization (ESAVI) of COVID-19 vaccines used in Chile or of special interest to Chile - May 4, 2021
2021
∙
CAVEI
Update of the CAVEI recommendation on the use of COVID-vaccines 19 in pregnant women - 27 April 2021
2021
3rd update of the NITAG-BF recommendation on vaccination against COVID 19 in Burkina Faso - September 2021
2021
∙
UNITAG
Accelerating COVID-19 Vaccine Uptake in Uganda
2021
∙
ACIP
ACIP Evidence to Recommendations for Use of Janssen COVID-19 Vaccine under an Emergency Use Authorization
2021
∙
ACIP
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years - May 12, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register